J. W. Coons Advisors LLC Invests $806,000 in Prestige Consumer Healthcare Inc. $PBH

J. W. Coons Advisors LLC bought a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 10,100 shares of the company’s stock, valued at approximately $806,000.

A number of other hedge funds have also recently made changes to their positions in PBH. UMB Bank n.a. boosted its stake in shares of Prestige Consumer Healthcare by 81.8% during the second quarter. UMB Bank n.a. now owns 320 shares of the company’s stock valued at $26,000 after purchasing an additional 144 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its stake in shares of Prestige Consumer Healthcare by 312.5% during the second quarter. Caitong International Asset Management Co. Ltd now owns 330 shares of the company’s stock valued at $26,000 after purchasing an additional 250 shares in the last quarter. Maseco LLP acquired a new stake in shares of Prestige Consumer Healthcare during the second quarter valued at about $27,000. Geneos Wealth Management Inc. boosted its stake in shares of Prestige Consumer Healthcare by 92.8% during the first quarter. Geneos Wealth Management Inc. now owns 559 shares of the company’s stock valued at $48,000 after purchasing an additional 269 shares in the last quarter. Finally, Costello Asset Management INC acquired a new stake in shares of Prestige Consumer Healthcare during the first quarter valued at about $112,000. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Stock Down 0.0%

Prestige Consumer Healthcare stock opened at $60.57 on Tuesday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38. Prestige Consumer Healthcare Inc. has a 52-week low of $59.62 and a 52-week high of $90.04. The firm has a 50 day moving average price of $63.53 and a two-hundred day moving average price of $73.68. The firm has a market cap of $2.98 billion, a price-to-earnings ratio of 14.22, a PEG ratio of 1.93 and a beta of 0.44.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.06). Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The firm had revenue of $249.53 million for the quarter, compared to the consensus estimate of $260.71 million. During the same quarter in the previous year, the business posted $0.90 EPS. The firm’s revenue for the quarter was down 6.6% compared to the same quarter last year. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. Equities analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on PBH. Sidoti raised Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 price target on the stock in a research note on Wednesday, September 24th. Wall Street Zen lowered Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Jefferies Financial Group cut their price target on Prestige Consumer Healthcare from $75.00 to $71.00 and set a “hold” rating on the stock in a research note on Monday, October 27th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research note on Wednesday, October 8th. Finally, Oppenheimer cut their price objective on Prestige Consumer Healthcare from $82.00 to $72.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 21st. Four investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $87.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.